Unresectable Cutaneous Squamous Cell Carcinoma of the Forehead With MLH1 Mutation Showing Dramatic Response to Programmed Cell Death Protein 1 Inhibitor Therapy
Clinical Skin Cancer · 2016
DOI: 10.1016/j.clsc.2016.11.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Skin Cancer, 2016. Verfasst von Jed H Assam und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of South Dakota Sanford School of Medicine 1400 W 22 St., Sioux Falls, SD 57105, United States. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, University of South Dakota Sanford School of Medicine 1400 W 22 St., Sioux Falls, SD 57105, United States.
- Department of Internal Medicine, University of South Dakota Sanford School of Medicine, 1400 W 22 St., Sioux Falls, SD 57105, United States.
Förderung
- NCI NIH HHS
Zitieren
APA
Assam, J. H., Powell, S., & Spanos, W. C. (2016). Unresectable Cutaneous Squamous Cell Carcinoma of the Forehead With MLH1 Mutation Showing Dramatic Response to Programmed Cell Death Protein 1 Inhibitor Therapy. Clinical Skin Cancer. https://doi.org/10.1016/j.clsc.2016.11.001
Vancouver
Assam JH, Powell S, Spanos WC. Unresectable Cutaneous Squamous Cell Carcinoma of the Forehead With MLH1 Mutation Showing Dramatic Response to Programmed Cell Death Protein 1 Inhibitor Therapy. Clinical Skin Cancer. 2016. doi:10.1016/j.clsc.2016.11.001
BibTeX
@article{Assam2016,
author = {Assam, Jed H and Powell, Steven and Spanos, William C},
title = {Unresectable Cutaneous Squamous Cell Carcinoma of the Forehead With MLH1 Mutation Showing Dramatic Response to Programmed Cell Death Protein 1 Inhibitor Therapy},
journal = {Clinical Skin Cancer},
year = {2016},
doi = {10.1016/j.clsc.2016.11.001}
}
EUVIMED